Skip to main content

The rockefeller university

Events & Lectures

CRC header image
Tuesday, April 01 | 12:00 PM - 1:00 PM | Carson Family Auditorium (CRC)

Chemical Biology-led Unraveling of the TG2/LRP1 Pathway for Antigen Presentation in Celiac Disease

Chemical & Structural Biology Seminar Series

Chaitan Khosla, Ph.D., Wells H. Rauser and Harold M. Petiprin Professor and professor of chemistry and, by courtesy, of biochemistry, department of chemical engineering, Stanford University

View Event
Tuesday, April 01 | 4:00 PM - 5:00 PM | Carson Family Auditorium (CRC)

Architectural Constraints on Recurrent Network Dynamics

Center for Studies in Physics and Biology Seminars

Carina Curto, Ph.D., Pablo J. Salame Goldman Sachs Professor of Computational Neuroscience, Brown University

View Event
Wednesday, April 02 | 10:30 AM - 11:30 AM | M-107, MSKCC, 1275 York Ave.

Characterizing Germline Cancer Mechanisms at Scale: Risk, Tumor Evolution, and Treatment Outcomes

Computational Systems and Biology Program

Alexander Gusev, Ph.D., associate professor, Dana-Farber Cancer Institute, Harvard Medical School

View Event
Wednesday, April 02 | 12:00 PM - 1:00 PM | Carson Family Auditorium (CRC)

Adaptation and Resistance to Antibiotics in Mycobacterium abscessus: Mechanisms, Regulation, and Therapeutic Implications

Seminars in Clinical Research

Pallavi Ghosh, M.D., Ph.D., principal investigator, Wadsworth Center, New York State Department of Health

View Event
Thursday, April 03 | 2:00 PM - 3:00 PM | 116 Rockefeller Research Laboratories, MSKCC, 430 E. 67th St.

In Vitro Reconstitution of Mammalian Life Cycle

Developmental Biology Program

Nobuhiko Hamazaki, Ph.D., assistant professor, University of Washington

View Event
Displaying 2 of 166 events.

Upcoming Events

Science and Medicine Outside Academia

| CARSON FAMILY AUDITORIUM (CRC)
Insight Lecture Series
Sarah Ackerman, Ph.D., program manager, United States Department of State
Cameron Bess, Ph.D., project officer and biologist, Biomedical Advanced Research and Development Authority (BARDA), United States Department of Health and Human Services
Tshaka Cunningham, Ph.D., co-founder and chief scientific officer, Polaris Genomics; co-founder and executive director, Faith-Based Genetic Research Institute; chief scientific officer, Athari BioScience, Inc.
Maryam Zaringhalam, Ph.D., NLM data science and open science officer, The National Institutes of Health; senior producer, The Story Collider

Test Insight Lecture

| CASPARY AUDITORIUM
Insight Lecture Series

Academic Lectures and Symposia

A rich program of lectures and seminars featuring internal and external speakers help Rockefeller scientists keep abreast of their colleagues’ work and forge fruitful interdisciplinary collaborations.

Join Our Programs and Special Events at The Rockefeller University

Join us for special events and programming that illuminate our work and support the exceptional researchers who lead it.

Contact Us

The Rockefeller University
1230 York Avenue
New York, NY
10065

Upcoming Events

Chemical Biology-led Unraveling of the TG2/LRP1 Pathway for Antigen Presentation in Celiac Disease

| CARSON FAMILY AUDITORIUM (CRC)

Architectural Constraints on Recurrent Network Dynamics

| CARSON FAMILY AUDITORIUM (CRC)

Characterizing Germline Cancer Mechanisms at Scale: Risk, Tumor Evolution, and Treatment Outcomes

| M-107, MSKCC, 1275 YORK AVE.

News

Clinical trials show new antibody therapy offers long-lasting HIV control without daily medication

Results presented at Conference on Retroviruses and Opportunistic Infections show that two broadly neutralizing antibodies can keep HIV suppressed for months.

Weill Cancer Hub East launched to unlock immunotherapy's full potential

This bold, multi-institutional collaboration will investigate how metabolism, diet, and gut microbes shape immune responses to cancer.

Study implicates 60 genes in congenital heart disease, including some that also contribute to related disorders such as autism

A surprising mix of inherited and de novo mutations in 60 genes contribute to 10 percent of CHD cases. Many of these same mutations also contribute to neurodevelopmental disorders including autism.